Engels Obi, Angel Investor

I am a Director of Global Outcomes Research at Merck, currently leading Value and Implementation strategy and execution for cardiovascular disease products. In this role, I generate and communicate robust evidence that demonstrates the clinical and economic value of Merck's innovative products and solutions for stakeholders including patients, providers, and payers. In addition to my MBA training from Columbia Business School and PhD in Pharmacy Administration from Purdue University, I have diverse competencies and expertise in product strategy, market access, health economics and outcomes research, real-world evidence, sales, regulatory affairs, and clinical pharmacy practice. I am also an active angel investor, syndicating financing of disruptive and impact-driven startups in emerging markets.